m6A-centered Drug Response Information

General Information of the Drug (ID: M6APDG02075)
Name
SYMBIOPOLYOL
Synonyms
SYMBIOPOLYOL
    Click to Show/Hide
Status
Investigative
Structure
3D MOL
2D MOL
Formula
C60H99NaO23S
InChI
1S/C60H100O23S.Na/c1-5-6-7-8-9-10-11-12-13-14-17-20-26-44(65)54(73)59-57(76)48(69)36-50(83-59)58(77)51(70)38(3)29-31-42(63)49-35-47(68)56(75)60(82-49)55(74)45(66)33-37(2)28-30-41(62)34-46(67)53(72)39(4)52(71)43(64)27-22-21-25-40(61)24-19-16-15-18-23-32-81-84(78,79)80;/h5,8-13,19-22,24,26,33,39-77H,1,3,6-7,14-18,23,25,27-32,34-36H2,2,4H3,(H,78,79,80);/q;+1/p-1/b9-8+,11-10+,13-12+,22-21+,24-19+,26-20+,37-33+;/t39?,40?,41-,42+,43?,44+,45+,46-,47+,48+,49+,50+,51-,52?,53+,54-,55-,56+,57+,58-,59-,60-;/m0./s1
InChIKey
FTLCRLMIOGRCRI-ZJJHBUFWSA-M
PubChem CID
46872950
TTD Drug ID
D04RGN
Target Gene(s) and Their Upstream m6A Regulator, Together with the Effect of Target Gene(s) in Drug Response
The target genes involved in drug-target interaction (such as drug-metabolizing enzymes, drug transporters and therapeutic targets) and drug-mediated cell death signaling (including modulating DNA damage and repair capacity, escaping from drug-induced apoptosis, autophagy, cellular metabolic reprogramming, oncogenic bypass signaling, cell microenvironment, cell stemness, etc.) could be regulated by m6A regulator(s) and affected their corresponding drug response. You can browse detailed information on drug-related target gene(s) mediated by m6A regulators.
VCAM-1 messenger RNA (VCAM1 mRNA)
Fat mass and obesity-associated protein (FTO)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary VCAM-1 messenger RNA (VCAM1 mRNA) is a therapeutic target for SYMBIOPOLYOL. The Fat mass and obesity-associated protein (FTO) has potential in affecting the response of SYMBIOPOLYOL through regulating the expression of VCAM-1 messenger RNA (VCAM1 mRNA). [1], [2]
Insulin-like growth factor-binding protein 3 (IGFBP3)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary VCAM-1 messenger RNA (VCAM1 mRNA) is a therapeutic target for SYMBIOPOLYOL. The Insulin-like growth factor-binding protein 3 (IGFBP3) has potential in affecting the response of SYMBIOPOLYOL through regulating the expression of VCAM-1 messenger RNA (VCAM1 mRNA). [2], [3]
References
Ref 1 N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells. Arterioscler Thromb Vasc Biol. 2022 May;42(5):644-658. doi: 10.1161/ATVBAHA.121.317295. Epub 2022 Mar 17.
Ref 2 US patent application no. 6,312,900, Antisense oligonucleotide compositions and methods for the modulation of activating protein 1.
Ref 3 IGFBP-3 stimulates human osteosarcoma cell migration by upregulating VCAM-1 expression. Life Sci. 2021 Jan 15;265:118758. doi: 10.1016/j.lfs.2020.118758. Epub 2020 Nov 12.